现代诊断与治疗
現代診斷與治療
현대진단여치료
MODERN DIAGNOSIS AND TREATMENT
2015年
10期
2171-2173
,共3页
颌骨造釉细胞瘤%复发%因素
頜骨造釉細胞瘤%複髮%因素
합골조유세포류%복발%인소
Jaw bone tumor%Recurrence%Factors
目的:探讨颌骨造釉细胞瘤术后复发的临床因素。方法回顾性分析64例造釉细胞瘤复发患者临床资料,观察肿物部位、X线表现、手术方式及病理类型与复发之间的关系。结果肿物部位中上颌复发率为30.77%;下颌复发率为18.46%,两者比较,差异具有统计学意义(P<0.05);X 线表现中单房者复发率为38.16%,多房者复发率为12.86,两者比较,差异具有统计学意义(P<0.05);保守手术患者复发率为53.03%。根治性手术患者复发率为9.55%,两者比较,差异具有统计学意义(P<0.05);复发患者中以滤泡型为主,占76.79%。结论造釉细胞瘤与瘤体部位、X线表现及临床病理等因素相关,临床应根据以上因素,选择正确的手术方式,彻底治疗,减少复发。
目的:探討頜骨造釉細胞瘤術後複髮的臨床因素。方法迴顧性分析64例造釉細胞瘤複髮患者臨床資料,觀察腫物部位、X線錶現、手術方式及病理類型與複髮之間的關繫。結果腫物部位中上頜複髮率為30.77%;下頜複髮率為18.46%,兩者比較,差異具有統計學意義(P<0.05);X 線錶現中單房者複髮率為38.16%,多房者複髮率為12.86,兩者比較,差異具有統計學意義(P<0.05);保守手術患者複髮率為53.03%。根治性手術患者複髮率為9.55%,兩者比較,差異具有統計學意義(P<0.05);複髮患者中以濾泡型為主,佔76.79%。結論造釉細胞瘤與瘤體部位、X線錶現及臨床病理等因素相關,臨床應根據以上因素,選擇正確的手術方式,徹底治療,減少複髮。
목적:탐토합골조유세포류술후복발적림상인소。방법회고성분석64례조유세포류복발환자림상자료,관찰종물부위、X선표현、수술방식급병리류형여복발지간적관계。결과종물부위중상합복발솔위30.77%;하합복발솔위18.46%,량자비교,차이구유통계학의의(P<0.05);X 선표현중단방자복발솔위38.16%,다방자복발솔위12.86,량자비교,차이구유통계학의의(P<0.05);보수수술환자복발솔위53.03%。근치성수술환자복발솔위9.55%,량자비교,차이구유통계학의의(P<0.05);복발환자중이려포형위주,점76.79%。결론조유세포류여류체부위、X선표현급림상병리등인소상관,림상응근거이상인소,선택정학적수술방식,철저치료,감소복발。
A bstract: Objective To investigate the clinical factors of postoperative recurrence of the jaw bone tumor. Methods The clinical data of 64 patients with recurrent tumor recurrence were ret-rospectively analyzed, and the relationship between tumor location, X-ray manifestations, surgical methods, pathological types and recurrence was observed. Results The rate of recurrence of max-illary tumor site was 30.77%; mandibular relapse rate for 18.46%,in comparison, the difference was statistically significant (P<0.05); X-ray manifestations in single room recurrence rate was 38.16%, real recurrence rate was 12.86, in comparison, the difference was statistically significant (P<0.05);conservative surgery in the patients with recurrence rate is 53.03%. The recurrence rate was 9.55%, the difference was statistically significant (P<0.05), and the recurrence rate was 76.79%. Conclusions The factors related to the site, X-ray features and clinical pathology of the tumor are related to the site of the tumor, and the clinical manifestations should be chosen according to the above factors.